Literature DB >> 2432900

Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin.

G Marone, M Columbo, M Triggiani, R Cirillo, A Genovese, S Formisano.   

Abstract

Forskolin, a diterpene compound isolated from the roots of Coleus forskohlii, activates adenylate cyclase in membranes from a variety of mammalian tissues. We found that forskolin (10(-7) to 3 X 10(-5) M) caused a concentration-related inhibition of IgE-mediated release of histamine and peptide leukotriene C4 (LTC4) from human basophils and lung mast cells. There was a significant linear correlation between the per cent inhibition of histamine and LTC4 release from both cell types. However, in both systems forskolin exerted a significantly greater inhibitory effect on LTC4 release than on histamine release. The concentration-response inhibition curve was paralleled by a forskolin-induced rise in cAMP levels in human leukocyte and mast cell preparations. The relationship between the effect of forskolin and the cAMP concentration was supported by the finding that forskolin inhibited the "first stage" of antigen-induced histamine release, but not the release caused by the Ca2+ ionophore, A23187. Propranolol, a competitive beta-receptor antagonist, did not block the inhibition of mediator release or the cAMP accumulation caused by forskolin. These data suggest that forskolin modulates the release of mediators of immediate hypersensitivity reactions via the activation of adenylate cyclase in human basophils and mast cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432900     DOI: 10.1016/0006-2952(87)90377-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.

Authors:  C Schudt; S Winder; S Forderkunz; A Hatzelmann; V Ullrich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

Review 2.  The role of cAMP regulation in controlling inflammation.

Authors:  A R Moore; D A Willoughby
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

3.  Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation.

Authors:  J Raud
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

4.  Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain.

Authors:  Mariana L Vale; Verônica M Benevides; Daniela Sachs; Gerly A C Brito; Francisco A C da Rocha; Stephen Poole; Sérgio H Ferreira; Fernando Q Cunha; Ronaldo A Ribeiro
Journal:  Br J Pharmacol       Date:  2004-11-01       Impact factor: 8.739

5.  Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophils.

Authors:  G Marone; C Stellato; A Renda; A Genovese
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  A review on herbal antiasthmatics.

Authors:  Ravindra G Mali; Avinash S Dhake
Journal:  Orient Pharm Exp Med       Date:  2011-07-05

Review 7.  The Glyoxalase System and Methylglyoxal-Derived Carbonyl Stress in Sepsis: Glycotoxic Aspects of Sepsis Pathophysiology.

Authors:  Thomas Schmoch; Florian Uhle; Benedikt H Siegler; Thomas Fleming; Jakob Morgenstern; Peter P Nawroth; Markus A Weigand; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-03-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.